In conclusion, several glycemic dysregulations, such as insulin resistance measured by HOMA-IR, diabetes status, longer duration of diabetes, poor glycemic control and higher levels of HbA1c, and insulin treatment were associated with greater cognitive decline in older individuals with overweight/obesity at high cardiovascular disease risk in a short time period. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.